Figure 11From: Occurrence of genetic modifications in core, 5′UTR and NS5b of HCV associated with viral response to treatment Phosphorylation sites predicted in the NS5B protein sequences for both treatment groups (A): group 1 (with SVR); (B): group 2 (non-responders). Back to article page